Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cross Country Healthcare (CCRN) EBIT Margin: 2009-2024

Historic EBIT Margin for Cross Country Healthcare (CCRN) over the last 16 years, with FY2024 value amounting to 1.25%.

  • Cross Country Healthcare's EBIT Margin fell 32900.0% to 2.39% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.44%, marking a year-over-year decrease of 14400.0%. This contributed to the annual value of 1.25% for FY2024, which is 68400.0% down from last year.
  • As of FY2024, Cross Country Healthcare's EBIT Margin stood at 1.25%, which was down 68400.0% from 5.58% recorded in FY2023.
  • In the past 5 years, Cross Country Healthcare's EBIT Margin ranged from a high of 9.63% in FY2022 and a low of 1.25% during FY2024
  • Over the past 5 years, Cross Country Healthcare's median EBIT Margin value was 5.58% (recorded in 2023), while the average stood at 4.23%.
  • Its EBIT Margin has fluctuated over the past 5 years, first skyrocketed by 94000bps in 2021, then plummeted by -68400bps in 2024.
  • Annual analysis of 5 years shows Cross Country Healthcare's EBIT Margin stood at 1.1% in 2020, then surged by 859bps to 8.31% in 2021, then increased by 16bps to 9.63% in 2022, then plummeted by -42bps to 5.58% in 2023, then tumbled by -122bps to 1.25% in 2024.
  • Its EBIT Margin stands at 1.25% for FY2024, versus 5.58% for FY2023 and 9.63% for FY2022.